ES2044834T3 - Procedimiento para la obtencion de tioeteres aromaticos. - Google Patents

Procedimiento para la obtencion de tioeteres aromaticos.

Info

Publication number
ES2044834T3
ES2044834T3 ES86117740T ES86117740T ES2044834T3 ES 2044834 T3 ES2044834 T3 ES 2044834T3 ES 86117740 T ES86117740 T ES 86117740T ES 86117740 T ES86117740 T ES 86117740T ES 2044834 T3 ES2044834 T3 ES 2044834T3
Authority
ES
Spain
Prior art keywords
represents hydrogen
radical
alkyl
single bond
symbols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86117740T
Other languages
English (en)
Inventor
Sprecher Andreas Dr Von
Werner Dr Breitenstein
Andreas Dr Beck
Robert W Dr Lang
Konrad Dr Oertle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2044834T3 publication Critical patent/ES2044834T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/19Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

NUEVO TIPO DE TIOETER NO SIMETRICO DE LA FORMULA (I) DONDE LOS SIMBOLOS GENERALES TIENEN LOS SIGUIENTES SIGNIFICADOS: R0 ES HIDROGENO O C1-ALCANOILO; R1 ES C1-C3 ALQUILO, QUE PUEDE SER SUSTITUIDO POR UNO O MAS HALOGENOS CON NUMERO MAXIMO DE 17 ATOMOS, R2 ES UN RESTO ALIFATICO CON 5-15C ATOMOS, A ES ETILENO, EL ENLACE SENCILLO O VINILENO; B1 ES C1-7-ALQUILENO O FENILENO; B2 ES UN ENLACE SENCILLO, ETILENO O FENILENO; Y M ES UN RESTO AROMATICO DE LA FORMULA PARCIAL (M) CON LOS SIGUIENTES SIGNIFICADOS DE LOS SIMBOLOS: R3 ES HIDROGENO O C1-4ALQUILO; X ES NH, O, S O CUANDO R4 ES HIDROGENO, EL ENLACE SIMPLE; UNO DE LOS SIMBOLOS R4 Y R5 SIGNIFICA HIDROGENO, Y EL OTRO EL GRUPO -CO-R6, O R4 Y R5 JUNTOS SIGNIFICAN EL RESTO -CO-C(R6)=C(R7)- O -CO-C(R7) =C(R6)O R4 Y R5 JUNTO CON X SIGNIFICAN EL RESTO -N=C(R8) -C(R6)=CH-; DONDE R6 ES -(CH2)B-COOR3, (DONDE B=0 A 2); R7 ES HIDROGENO O C1-4-ALQUILO Y R8 ES HIDROGENO, METILO, METOXI O HALOGENO Y SUS SALES SON ACTIVAS COMO ANTAGONISTAS DE LEUKOTRIENO Y APROPIADAS PARA TRATAMIENTO DE ESTADOS ALERGICOS Y ASMATICOS.
ES86117740T 1985-12-23 1986-12-19 Procedimiento para la obtencion de tioeteres aromaticos. Expired - Lifetime ES2044834T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH551385 1985-12-23
CH132186 1986-04-04

Publications (1)

Publication Number Publication Date
ES2044834T3 true ES2044834T3 (es) 1994-01-16

Family

ID=25687324

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86117740T Expired - Lifetime ES2044834T3 (es) 1985-12-23 1986-12-19 Procedimiento para la obtencion de tioeteres aromaticos.

Country Status (16)

Country Link
US (1) US4785004A (es)
EP (1) EP0228045B1 (es)
KR (1) KR870005986A (es)
AT (1) ATE62223T1 (es)
AU (1) AU6681786A (es)
CA (1) CA1274522A (es)
DE (1) DE3678545D1 (es)
DK (1) DK624286A (es)
ES (1) ES2044834T3 (es)
FI (1) FI865241A (es)
GR (1) GR3001727T3 (es)
HU (1) HUT46658A (es)
IL (1) IL81056A0 (es)
NO (1) NO865233L (es)
NZ (1) NZ218762A (es)
PT (1) PT83992B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017583A (en) * 1983-04-21 1991-05-21 Merck Frosst Canada, Inc. Leukotriene antagonists
GB8523776D0 (en) * 1985-09-26 1985-10-30 Scras Catechol derivatives
GB8709546D0 (en) * 1987-04-22 1987-05-28 Lilly Industries Ltd Pharmaceutical use of organic compounds
GB8709547D0 (en) * 1987-04-22 1987-05-28 Lilly Industries Ltd Organic compounds
DE3724735A1 (de) * 1987-07-25 1989-02-02 Hoechst Ag Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten, sowie vorprodukte
DE3724669A1 (de) * 1987-07-25 1989-02-02 Hoechst Ag Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten
GB8725260D0 (en) * 1987-10-28 1987-12-02 Lilly Industries Ltd Organic compounds
GB8807016D0 (en) * 1988-03-24 1988-04-27 Lilly Industries Ltd Organic compounds & their pharmaceutical use
US5149717A (en) * 1988-03-29 1992-09-22 Ciba-Geigy Corporation Alkanophenones useful for treating allergies
IL89713A0 (en) * 1988-03-29 1989-09-28 Ciba Geigy Ag Novel alkanophenones
IL93765A (en) * 1989-04-11 1995-08-31 Basf Ag Oxirane Phenyl Esters and fungicides containing them
EP0419411A3 (en) * 1989-09-19 1991-09-04 Ciba-Geigy Ag Additional alkanophenones
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
GB9015892D0 (en) * 1990-07-19 1990-09-05 Tioxide Group Services Ltd Compositions
EP3133067A1 (en) 2015-08-21 2017-02-22 Merck Patent GmbH Compounds for optically active devices
EP3133065A1 (en) * 2015-08-21 2017-02-22 Merck Patent GmbH Compounds for optically active devices
EP3133066A1 (en) 2015-08-21 2017-02-22 Merck Patent GmbH Hydrophilic compounds for optically active devices
EP3363786A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Compounds for optically active devices
EP3363793A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Hydrophobic compounds for optically active devices
US20210355113A1 (en) 2018-07-23 2021-11-18 Bristol-Myers Squibb Company Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609744A (en) * 1983-04-21 1986-09-02 Merck Frosst Canada Inc. 4-oxo-benzopyran carboxylic acids
EP0123543B1 (en) * 1983-04-21 1988-02-03 Merck Frosst Canada Inc. Leukotriene antagonists, their production and use and compositions containing them
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
EP0170048B1 (de) * 1984-06-28 1991-04-17 Ciba-Geigy Ag Aliphatische Thioether

Also Published As

Publication number Publication date
US4785004A (en) 1988-11-15
HUT46658A (en) 1988-11-28
DE3678545D1 (en) 1991-05-08
FI865241A0 (fi) 1986-12-19
KR870005986A (ko) 1987-07-08
AU6681786A (en) 1987-06-25
NO865233L (no) 1987-06-24
NZ218762A (en) 1989-01-27
PT83992A (de) 1987-01-01
EP0228045A2 (de) 1987-07-08
GR3001727T3 (en) 1992-11-23
NO865233D0 (no) 1986-12-22
FI865241A (fi) 1987-06-24
PT83992B (pt) 1989-07-31
DK624286D0 (da) 1986-12-22
CA1274522A (en) 1990-09-25
IL81056A0 (en) 1987-03-31
DK624286A (da) 1987-06-24
ATE62223T1 (de) 1991-04-15
EP0228045A3 (en) 1988-09-07
EP0228045B1 (de) 1991-04-03

Similar Documents

Publication Publication Date Title
ES2044834T3 (es) Procedimiento para la obtencion de tioeteres aromaticos.
ES491225A0 (es) Procedimiento para la preparacion de 2,4-diamino-pirimidin-5-carbanilidas
ATE39483T1 (de) Kondensierte pyrrolinon-derivate, und ihre herstellung.
PT75460A (en) 2-<2'-hydroxy-3'-(1,1-dimethylpropylamino)-propoxy>-beta-phenylpropiophenone its acid addition salts process for its preparation and pharmaceutical compositions
SE8207224L (sv) Nya aromatiska aminoalkoxiderivat, deras framstellning och deras terapeutiska anvendning
ES2040205T3 (es) Procedimiento para la obtencion de alfa-hidroxitioeteres.
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.
PT78155B (de) N-(3-trifluormethylphenyl)-n'-propargylpiperazin seine herstellung und verwendung
DE3361628D1 (en) Substituted 5-phenylthio-6-amino-pyrimidinones, process for their preparation and their use, and preparations containing these compounds
DK106287A (da) Glycero-3(2)-phospho-l-serin-derivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse
SE7602856L (sv) Nya substituerade arylalkylaminer
JPS5513285A (en) Imidazoline compound and medical composition
DE69203142D1 (de) Von l-Glutaminsäure abgeleitete Süssungsmittel, Verfahren zu ihrer Herstellung.
DE3365954D1 (en) The use of alpha, alpha-dialkyl adamanthylethylamines to treat measles
JPS5515482A (en) Imidazoline compound and medical composition
SE7614473L (sv) Nya aminer
DK214884A (da) Chlorphenoxyacetatderivat

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 228045

Country of ref document: ES